Search Results - Maher Issa
- Showing 1 - 2 results of 2
-
1
Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis by Josef S Smolen, Yoshiya Tanaka, Michelle Petri, Inmaculada de la Torre, Thomas Dörner, Gabriella Meszaros, Hong Zhang, Maher Issa, Eric Morand, Christina Dickson, Maria Silk
Published in RMD Open (2023-08-01)Get full text
Article -
2
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials by Thomas Bieber, Norito Katoh, Eric L. Simpson, Marjolein de Bruin-Weller, Diamant Thaçi, Antonio Torrelo, Angelina Sontag, Susanne Grond, Maher Issa, Xiaoyu Lu, Tracy Cardillo, Katrin Holzwarth, Jacob P. Thyssen
Published in Journal of Dermatological Treatment (2023-12-01)Get full text
Article
